SCHEMBL8739857

SCHEMBL8739857

Cc1ccc2c3ccc(C)cc3n(-c3cccc(-n4c5cc(C)ccc5c5ccc(C)cc54)c3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
MAT2A P31153 1/20 0.40
KDM4E B2RXH2 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
ATM Q13315 1/20 0.40
ACHE P22303 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
KMT2A Q03164 1/20 0.38
NOTUM Q6P988 1/20 0.38
HSP90AA1 P07900 1/20 0.37
MGLL Q99685 1/20 0.37
CYP2A6 P11509 1/20 0.36
FGFR1 P11362 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8739856 0.93 KDM4E (0.53) CYP1A2MAT2AKDM4EL3MBTL1ATM
SCHEMBL8739860 0.90 GAA (0.39) CYP1A2MAT2AKDM4EL3MBTL1ATM
SCHEMBL679025 0.88 KDM4E (0.56) MAT2AKDM4EL3MBTL1ATMACHE
SCHEMBL26226128 0.87 KDM4E (0.47) MAT2AKDM4EL3MBTL1ATMACHE
SCHEMBL10090560 0.84 KDM4E (0.48) MAT2AKDM4EL3MBTL1ATMALDH1A1
SCHEMBL8739861 0.84 KDM4E (0.48) MAT2AKDM4EL3MBTL1ATMALDH1A1
SCHEMBL8282722 0.83 MEN1 (0.41) CYP1A2KDM4EL3MBTL1ATMACHE
SCHEMBL13158509 0.83 FGFR1 (0.41) MAT2AKDM4EL3MBTL1TDP1ALDH1A1
SCHEMBL9973674 0.83 HTT (0.44) CYP1A2KDM4EL3MBTL1ATMACHE
SCHEMBL883474 0.82 KDM4E (0.67) MAT2AKDM4EL3MBTL1ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160254462-A1 Material For Organic Electroluminescence Device And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2016-09-01 US disclosed
US-9340728-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2016-05-17 US disclosed
US-9318714-B2 Material for organic electroluminescence device and organic electroluminescence device UDC Ireland (IE) 2016-04-19 US disclosed
US-9193747-B2 Organic electroluminescent device UDC IRELAND LIMITED (IE) 2015-11-24 US disclosed
US-8735878-B2 Charge transporting material and organic electroluminescence device UDC IRELAND LIMITED (IE) 2014-05-27 US disclosed
US-8679649-B2 Material for organic electroluminescence device, and organic electroluminescence device UDC IRELAND LIMITED (IE) 2014-03-25 US disclosed
US-20130270530-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND UDC IRELAND LIMITED (IE) 2013-10-17 US disclosed
US-20120256173-A1 CHARGE TRANSPORTING MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-10-11 US disclosed
US-20120169218-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-07-05 US disclosed
US-20120126221-A1 CHARGE-TRANSPORTING MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-05-24 US disclosed
US-20120126690-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION 2012-05-24 US disclosed
US-20110049497-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed
US-20100171111-A1 ORGANIC ELECTROLUMINESCENT DEVICE FUJIFILM CORPORATION (JP) 2010-07-08 US disclosed
US-20080191618-A1 ORGANIC ELECTROLUMINESCENCE DEVICE UDC IRELAND LIMITED (IE) 2008-08-14 US disclosed
US-20080191618-A1 ORGANIC ELECTROLUMINESCENCE DEVICE UDC IRELAND LIMITED (IE) 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100171111-A1 ORGANIC ELECTROLUMINESCENT DEVICE NDUFS3, NDUFS2, NDUFS4 CYP1A2 1090/4885MAT2A 4828/4885KDM4E 2299/4885
US-20120126221-A1 CHARGE-TRANSPORTING MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE SLC26A3, SLC43A3, SLCO2A1 CYP1A2 805/4885MAT2A 4612/4885KDM4E 4092/4885
US-20160254462-A1 Material For Organic Electroluminescence Device And Organic Electroluminescence Device VCL, L1CAM, EML4 CYP1A2 3224/4885MAT2A 4445/4885KDM4E 374/4885
US-20120256173-A1 CHARGE TRANSPORTING MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE SLCO4C1, SLC39A3, SLC39A11 CYP1A2 1257/4885MAT2A 4737/4885KDM4E 3988/4885
US-20110049497-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE VCL, L1CAM, EML4 CYP1A2 3224/4885MAT2A 4445/4885KDM4E 374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.